MedTrace Logo

Effect of Fluvastatin on Brown Fat Activity

NCT03189511 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2018-05-31

No results posted yet for this study

Summary

The purpose of this study is to elucidate the effects of Fluvastatin on brown adipose tissue activity in humans.

Conditions

Interventions

DRUG

Fluvastatin

Fluvastatin 40 mg twice daily per mouth for 14 days.

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Irene A Burger, M.D. · University of Zurich

Study Design

Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2018-01-23
Completion
2018-02-19

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189511 on ClinicalTrials.gov